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INTRODUCTION
Cutaneous hypopigmentions enclose a wide range of 
disorders, which can be mainly differentiated based on the 
age of onset (congenital or acquired) [Table 1], the extent 
of involvement (diffuse or localized) and the underlying 
aetiology. Diffuse or generalized hypopigmentation in 
early childhood often have a genetic origin, in contrast 
to the acquired localized form at a later age. An adequate 
medical history and a thorough clinical evaluation are 
very useful tools to make a presumptive diagnosis, which 
can be followed by further diagnostic investigations. 
In routine clinical practice, the clinician can ask several 
key questions concerning age of onset (congenital or 
acquired), evolution of the lesions (stable or progressive), 
family history and associated disorders (e.g., autoimmune 
disorders, loss of sight or hearing, developmental 
disorders, neurological disorders, skeletal anomalies). In 
addition, other clinical features have been proven to be 
crucial in the differentiation of hypomelanoses: Subtype 
of pigment disorder (hypopigmentation, depigmentation 
or hyperpigmentation), distribution pattern and shape 
of the lesions (body location, unilateral or bilateral, 
solitary or multiple lesions, linear pattern, Blaschkoid 
distribution or leaf‑like pattern) or other distinct clinical 
findings (anomalies of hair, eyes, teeth, nervous system 
or skeleton).[1] In this paper, we describe the differential 
diagnosis of hypomelanoses in children (ranging from 
birth to end of puberty).
WOOD’S LIGHT EXAMINATION
In diagnosing pigmentary disorders, Wood’s light 
examination plays an important role, distinguishing 
hypo‑ and depigmentation. While a decreased 
Hypomelanosis of the skin is a frequently encountered problem in childhood, being totally innocent or representing 
the first sign of a multisystem disorder. Medical history, clinical examination, Wood’s light investigation, histological 
analysis of the skin and a multidisciplinary consultation can contribute to a correct and early diagnosis of the different 
types of hypopigmentations. In the present paper, we present a systematic clinical approach to the differential 
diagnosis of those skin disorders.
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Table 1: Most common congenital and acquired 
hypomelanoses
Congenital hypomelanoses Acquired hypomelanoses
Angelman syndrome Acquired nutritional deficiencies (e.g., 
kwashiorkor)
Chédiak-Higashi syndrome Generalized and segmental vitiligo
Cross syndrome Halo nevi
Elejalde syndrome Linear lichen sclerosus
Goltz syndrome
Griscelli syndrome
Secondary hypopigmentations/Post-
inflammatory,-infectious,-traumatic:
Hermansky-Pudlak
Incontinentia pigmenti stage IV
Inborn errors of metabolism 
(phenylketonuria, 
homocystinuria, 
histidinaemia)
Prader-Willi
Menkes syndrome
Nevus depigmentosus
Oculocutaneous albinism
Piebaldism
Pigmentary mosaicism
Tuberous sclerosis
Waardenburg syndrome
Woolf syndrome
Atopic dermatitis, chickenpox, 
injuries, impetigo, mycosis fungoides, 
insect bites, pityriasis lichenoides, 
pityriasis versicolor, pityriasis alba, 
lichen striatus, linear morphea, 
progressive macular hypomelanosis, 
tuberculoid leprosy
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Albinism
Two different  types of  albinism have been  identified: 
Ocular (OA) and OCA albinism.[3] In OCA, the ocular 
manifestations (including nystagmus, photophobia and 
iris  translucency) are often  the first  clue  leading  to  the 
diagnosis. This clinical entity is divided into four subtypes 
with a wide variation in color of hair and skin, ranging from 
a pigmentless condition (OCA 1A) to subtle pigmentary 
dilution (OCA 1B‑4). Genetic counseling to specify the 
subtype of OCA is recommended to determine the 
prognosis and evolution as well as the consequences in case 
of possible pregnancy. Besides a stringent ophthalmologic 
follow up, dermatological care should focus on the 
development of (pre) malignant lesions, sun protection and 
cosmetic advice (camouflage). In the differential diagnosis 
of OCA other more rare syndromes of albinism, requiring 
an internal and pediatric work‑up, should be kept in 
mind.[4] These syndromes are characterized by defects in 
packaging of melanin and other cellular proteins, rather 
than by defects in melanin production seen in OCA. The 
Hermansky‑Pudlak syndrome can be suspected if there 
are signs of an associated platelet dysfunction: repeated 
episodes of epistaxis, abnormal development of bruise. 
The lysosomal ceroid storage defect, which is another 
finding in the Hermansky‑Pudlak syndrome, can cause 
pulmonary fibrosis, inflammatory bowel disease and 
Figure 1: diffuse hypomelanoses in children. OCA= oculocutaneous albinism, SD= syndrome, *Eye abnormalities: discussion, 
**Eye abnormalities also possible
pigment production is reported as hypopigmentation, 
depigmentation has been defined as  loss of pigment. 
In a similar way, partial lack of melanin is known as 
hypomelanosis while amelanosis is the total absence 
of melanin. In case of doubt, supplemental histological 
and electron microscopic investigations can be helpful.[2] 
Wood’s lamp inspection is particularly useful in lighter 
skin phototypes (I‑II), and neonates due to a decreased 
pigment contrast under visible light.
DIFFUSE HYPOMELANOSES
Diffuse hypomelanoses of the total body surface in 
children often have an underlying genetic cause [Figure 1]. 
Although the number of melanocytes can be normal in this 
group of conditions, there is a reduced melanin production 
or a reduced transport and/or transfer of melanosomes 
to the keratinocytes. During Wood’s light examination, a 
hypopigmentation rather than a complete depigmentation 
is observed. Multiple possible mechanisms have been 
proposed to explain the reduced melanogenesis: Absence 
of tyrosinase activity (oculocutaneous albinism [OCA] 
1A), reduced tyrosinase activity (OCA 1B), or impaired 
tyrosinase function caused by underlying metabolic 
disorders or nutritional deficiencies (copper, selenium or 
phenylalanine hydroxylase).[1]
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kidney disease.[5] On the other hand, patients with the 
Chédiak‑Higashi syndrome typically exhibit a silvery 
hair color, prolonged bleeding times, recurrent infections 
and large intracytoplasmic granules in the circulating 
polymorphonuclear cells [Table 2]. This syndrome should 
be differentiated from the Griscelli syndrome, which is a 
rare and often life‑threatening autosomal recessive disorder 
characterized by hypopigmentation, immunological and 
neurological deficiencies.[6] Children with the Elejalde 
syndrome have a similar clinical presentation, with silvery 
hair and neurological impairment, but lack immunological 
problems.[7] Other genetic disorders with associated 
pigmentary dilution of the skin are Cross syndrome, 
Woolf syndrome, Prader‑Willi and Angelman syndrome. 
Cross syndrome is a very rare oculocerebral syndrome 
defined by generalised hypopigmentation, psychomotor 
impairment, growth retardation and progressive 
neurological manifestations.[8] Woolf syndrome, also called 
Ziprkowski‑Margolis or albinism‑deafness syndrome, is 
an X‑linked disorder (gene locus Xq26.3‑q27.1). Affected 
boys have congenital neural deafness and a severe 
piebaldism‑like phenotype.[9] Children with Prader‑Willi 
syndrome present with infantile hypotonia, characteristic 
obesity, mental retardation, short stature and typical 
facial abnormalities; half of these patients have mild 
to moderate hypopigmentation. Hypopigmentation in 
Prader‑Willi patients correlates with a deletion of the P 
gene on chromosome 15 which is also affected in OCA2. 
Reduced pigmentation of the skin is also a common feature 
in Angelman syndrome.[10]
Inborn errors of metabolism and nutritional 
deficiencies
Certain inborn errors of metabolism can disturb 
melanin synthesis. Phenylketonuria is transmitted in an 
autosomal recessive manner and is caused by a deficiency 
of the enzyme phenylalanine hydroxylase, resulting in 
an accumulation of phenylalanine. The deficient melanin 
synthesis in infants with phenylketonuria results in 
very fair skin and hair. If the treatment (a lifelong low 
phenylalanine diet) is neglected, mental retardation, 
epilepsy and extra‑pyramidal signs can arise.[11]
Selenium deficiency is associated with a diffuse loss of 
pigmentation of hair and skin, both returning to normal 
after adequate supplementation.[12] As tyrosinase is a 
copper‑dependent enzyme in the melanin production 
process, hypopigmentation is a feature of copper 
deficiency,  as  observed  in patients with  the Menkes 
syndrome.[13]
Acquired nutritional deficiencies, with a lack of copper 
and selenium in particular, can cause a hypopigmentation 
of the skin, as well. In non‑developing countries, 
these conditions can be seen in children receiving 
long‑term parental nutrition or  in  case of  insufficient 
nutrition intake (kwashiorkor). The low protein intake 
in kwashiorkor  leads  to  specific  clinical  signs  such as 
edema, and changes in hair and skin pigmentation. The 
skin lesions are initially erythematous to red‑brown 
in color with marked desquamation. This can be 
followed by irregular or patchy skin discoloration (both 
hypomelanosis and hypermelanosis). The hypomelanosis 
usually begins on the face. Hypomelanotic kwashiorkor 
responds to dietary protein, although the skin is said to 
repigment slowly.
LOCALIZED HYPOMELANOSES
The differential diagnosis of localized hypomelanoses 
in children [Figure 2] can be based on the distinction 
between depigmentation and hypopigmentation, 
using Wood’s light examination. Furthermore, a 
careful medical history of the approximate time of 
onset can be helpful in differentiating congenital 
(e.g., piebaldism, Waardenburg syndrome) from acquired 
depigmentations (e.g., vitiligo). If a hypopigmentation is 
diagnosed with Wood’s light examination, clinical data 
about the number of lesions and their distribution will 
be most important to establish the final diagnosis.
Depigmentation
Vitiligo
Vitiligo is undoubtedly one of the most familiar 
forms of localized hypomelanoses (amelanoses) 
[Figure 3a]. It is an acquired condition resulting from the 
progressive loss of melanocytes. The usual age of onset 
is often between the age of 20 years and 30 years. The 
estimated prevalence is 0.5‑1%, without ethnic or gender 
preference. Depending on the pattern of skin lesions, 
which are typical milky white sharply demarcated 
Table 2: Cutaneous hypomelanoses with localized or 
diffuse light hair
White hair OCA1a
Light pigmented hair Chédiak-Higashi
Elejalde syndrome
Griscelli syndrome
Angelman/Prader Willi syndrome
Cross syndrome
Hermansky-Pudlak
Menkes syndrome
Nutritional deficiencies (selenium  deficiency, 
kwashiorkor…)
OCA1b, OCA2
Phenylketonuria, homocysteinuria, 
histidinaemia
Red hair OCA3
Patches of  
depigmented hair
Generalized and segmental vitiligo
Halo nevi
Piebaldism
Tuberous sclerosis
Waardenburg syndrome
Woolf syndrome
“Silvery” hair 
syndromes}
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maculae, vitiligo is divided into two different subtypes: 
generalized (non‑segmental) vitiligo (bilateral maculae, 
often distributed in an acrofacial pattern or scattered 
symmetrically over the entire body) and segmental 
vitiligo (unilateral maculae in a segmental/band shape 
distribution). The segmental type of vitiligo is more 
often seen in children, as it starts generally earlier in life 
than the non‑segmental one.[14] The diagnosis of vitiligo 
is essentially based on clinical examination because 
the lesions have a typical appearance. However, if the 
lesions are not distributed according to the classic vitiligo 
localizations, confusion with other hypomelanoses 
can arise. The presence of a family history for vitiligo, 
presence of Koebner phenomenon, of leukotrichia 
and associated autoimmune disorders such as thyroid 
disease are typical data by medical history that can 
support the diagnosis. On histological examination, a 
complete absence of melanocytes is reported, except in 
early lesions where some persistent melanocytes can be 
found. Current common conventional treatment options 
Figure 2: localised hypomelanoses in children. SD= syndrome
Figure 3: Depigmentation; (a) Vitiligo; (b) Halo nevi; (c) Piebaldism
a b c
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include topical steroids, topical calcineurin inhibitors or 
UV therapy, all of them often with variable results.
The association between vitiligo and halo nevi is well 
established, although they can also be present separately. 
A halo nevus is a melanocytic nevus which acquires a 
surrounding depigmented rim, resulting ultimately in 
a complete regression of the nevus [Figure 3b]. Several 
reports have been published regarding the development 
of vitiligo simultaneously or shortly after the occurrence 
of a halo nevus. In our previous study, halo nevi were 
present in 31.1% of all vitiligo patients.[15]
Piebaldism
Piebaldism [Figure 3c] is a rare autosomal dominant 
disorder with an underlying defect of the tyrosine 
kinase transmembrane receptor on melanocytes, leading 
to an impaired embryonic migration and survival of 
melanocytes in the skin. It results from a mutation in the 
c‑kit proto‑oncogene, mapped to the proximal long arm 
of chromosome 4 (4q12) or from deletions in the SLUG 
gene, which  is  a  zincfinger neural  crest  transcription 
factor. Recently reported cases of piebaldism, which 
are milder or more severe than genetically expected, 
indicate that other factors (e.g., a modifier gene of MC1R) 
influence skin and hair color.[16] Piebaldism is clinically 
characterized by congenital, extensive, symmetrically 
distributed depigmentations mainly on forehead, front of 
the thorax and extremities [Figure 3c]. The extent of the 
lesions is variable, ranging from only a midfrontal poliosis 
or white forelock (present in 80‑90% of the patients) and 
minimal areas of depigmentation to a depigmentation of 
almost the entire body and hair. Piebaldism should be 
differentiated from the Waardenburg syndrome, which 
is also an autosomal dominant disorder with a similar 
clinical presentation. It is associated with heterochromia 
iridis, dystopia canthorum, congenital deafness and 
occasionally a congenital megacolon (Hirschsprung’s 
disease). The Waardenburg syndrome is an expression of 
a neurocristopathy, not only involving the melanocytes 
in the skin, but also those at the level of the eyes, 
hair, cochlea and meninges. Four subtypes have been 
identified. Another differential diagnosis is vitiligo 
as comparable depigmented maculae are observed. 
However, the predominantly ventral distribution of the 
lesions, congenital character, the stable course, the white 
forelock and the presence of hyperpigmented maculae 
within the areas of depigmentation are suggestive for 
piebaldism.[16] Nowadays surgical grafting techniques 
offer a good therapeutic option for stable depigmentations 
as in piebaldism or segmental vitiligo. Surprisingly 
good results (with a success rate > 90%) have been 
reported with autologous non‑cultured epidermal cell 
transplantation [Figure 4a‑b]. With this technique, only 
a small patch of the patient’s normally pigmented skin 
is required to treat large surfaces of depigmentation.[17,18]
Hypopigmentation
Nevoid hypomelanoses and nevus depigmentosus
A common localized hypomelanosis seen in children is 
the nevus depigmentosus, which becomes visible from 
birth or in the 1st year of life and does not change in 
shape [Figure 5a]. Especially in the 1st year of life, some 
confusion is possible with segmental or focal vitiligo. 
Skin inspection with Wood’s light examination is an 
essential part in the diagnosis. In contrast to what its 
name suggests, the nevus depigmentosus presents itself 
as a hypopigmentation rather than a depigmentation. 
Other factors discriminating the nevus depigmentosus 
from vitiligo are the absence of a marked sensitivity to sun 
exposure and the potential of slightly tanning. According 
to some authors, there are three subtypes within the 
group of the nevi depigmentosi: an isolated form (solitary 
and well defined lesions), a segmental form (unilateral, 
band‑shaped lesions, sometimes Blaschkoid distribution) 
and a systematized from (extensive whorls and 
streaks of hypopigmentation, following the lines 
of Blaschko [hypomelanosis of Ito or pigmentary 
mosaicism]).[19] The theory of Happle postulates that all 
linear hypo‑ and depigmented maculae following the 
lines of Blaschko are a consequence of mosaicism, even 
though a chromosomal mosaicism could not always be 
demonstrated.[20] Whenever this blaschkoid pattern is 
seen, neurological and musculo‑skeletal abnormalities 
should be suspected. More recently it has been suggested 
that pigmentary mosaicism (of the ‘hypomelanosis of 
Ito’ type) can be regarded as a continuum of different 
subtypes, amongst which the pigmentary disorder can 
be present with and without associated neurological 
anomalies. This approach is contrary to the ancient 
view, in which the associated conditions were used as 
Figure 4: Piebaldism; (a) Before and (b) After treatment with 
non-cultured epidermal cell transplantation
a b
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a condition sine qua non to diagnose ‘hypomelanosis 
of Ito’. If present, the neurological anomalies usually 
manifest themselves within the 1st years of life. A recent 
study demonstrated that in 92.3% of patients with a 
linear hypo‑or hyperpigmentation following the lines 
of Blaschko, the associated neurological disorder was 
detected before the age of two.[21] Developmental disorders 
and epilepsy were the most reported problems. According 
to this study, neurological defects were more frequently 
observed in linear hyperpigmentations compared to linear 
hypopigmentations. There is no consensus in literature 
about the prevalence of neurological symptoms associated 
with  ‘hypomelanosis of  Ito’ as different definitions are 
being used. This percentage however, does appear to 
be higher in more disseminated forms, probably due 
to an earlier mutation in the embryogenesis compared 
to the localized nevus depigmentosus. A subsequent 
neurological, pediatric and genetic work‑up seems to 
be most appropriate in children under the age of two, 
presenting with a linear and/or Blaschkoid pattern of 
hypopigmentation. In asymptomatic children older than 
two, watchful waiting seems to be an acceptable strategy. 
More recently phylloid hypomelanoses has been described 
by Happle et al. as another pattern hypopigmentation.[22] 
It is a rare neurocutaneous syndrome characterized by 
hypopigmented leaf‑like or oblong macules reminiscent 
of floral ornaments. Associated extracutaneous anomalies 
include cerebral, Ocular, and skeletal defects. It has 
been suggested that this phenotype originates from 
mosaic partial or complete trisomy 13. Other entities 
to be considered in the differential diagnosis of linear 
hypomelanoses in children are lichen striatus, linear 
scleroderma, linear lichen sclerosis, post‑inflammatory or 
traumatic changes, incontinentia pigmenti stage IV and the 
Goltz‑syndrome. In a solitary rather round/oval lesion, 
distinction must be made with a nevus anaemicus, which 
is characterized by a normal presence of melanocytes and 
melanin and is based on vascular disturbances.
Tuberous sclerosis complex
Tuberous sclerosis is an autosomal dominant condition 
(mutation in tuberous sclerosis protein 1 gene [TSC1] 
and TSC2) resulting in a hyperplasia of ectodermal 
and mesodermal cells.[23] This rare multisystem genetic 
disease is characterized by the triad of seizures, mental 
retardation and hypopigmented oval (‘ash leaf spots’) 
or dot‑like (‘confetti’) maculae [Figure 5b]. Studies 
have shown that the likelihood of tuberous sclerosis 
is significantly higher if the patient has more than 
three of these hypopigmented maculae. The associated 
hamartomas found in several organs (brain, eyes, 
heart, kidneys, lungs and skin) are also typical. In the 
skin,  angiofibromas  in  the  face, periungual fibromas, 
and presence of a ‘shagreen’ patch can be found. The 
conditions associated with tuberous sclerosis generally 
become apparent between the age of five and late puberty. 
The decision of screening depends largely on the number 
of hypopigmented maculae as well as of the presence of 
other traits of the tuberous sclerosis complex. Additional 
investigations consist of neurological and ophthalmologic 
examinations, cranial computerized tomography and/or 
nuclear magnetic resonance (to look at the presence of 
calcifications). A renal and cardial echography should 
be performed to detect renal angiomyolipomas and 
cardial rhabdomyomas, which are diagnosed in 90% of 
tuberous sclerosis patients under the age of two. Finally, 
molecular analysis of the two tuberous sclerosis genes 
plays an important role in the diagnosis. Other entities to 
be considered in the differential diagnosis of oval round 
macular hypomelanoses are pityriasis alba, vitiligo, 
post‑inflammatory hypopigmentation (atopic dermatitis, 
pityriasis rosea, pityriasis lichenoides chronica), naevus 
anaemicus and lichen sclerosus.[24,25]
Secundairy hypopigmentations and hypopigmentations 
without pigment disorders
An acquired diminution or loss of melanin in the 
Figure 5: Hypopigmentation; (a) Naevus depigmentosus; (b) ‘Ash leaf’ macula in tuberous sclerosis
a b
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skin is detected in patients with post‑inflammatory 
hypomelanosis, which is influenced by inter‑individual 
differences in sensitivity. The hypopigmentation can be 
a consequence of an impaired transfer of melanin to the 
keratinocytes secondary to the inflammatory process or 
the result of application of potent topical steroids.
Pityriasis versicolor, caused by yeasts of the Malassezia 
genus, is one of the most common yeast infection associated 
with pigmentary changes. Well‑demarcated finely scaling 
patches, hyper‑ or hypopigmentations are found on clinical 
examination. If the lesions are hypopigmented, the name 
‘pityriasis versicolor alba’ has been used. As most Malassezia 
species are lipid‑dependent, pytiriasis versicolor is commonly 
seen in adolescence, associated with a high sebaceous 
activity in the skin. The clinical picture is often suggestive 
enough to establish the diagnosis, though confirmation by 
microscopy can be performed. A yellow‑green fluorescence 
may be observed on examination of affected areas with 
Wood’s light.[26] Pityriasis alba is another common 
dermatosis characterized by hypopigmentation, presenting 
with pale white, well  to moderate defined, very slightly 
scaling plaques. A relationship with sun exposure, xerosis 
cutis and atopy has been suggested. This disease is usually 
reported in children between 6 years and 16 years old, with 
lesions typically occurring in the face and upper arms.[27] 
Lichen striatus is an asymptomatic linear dermatosis that 
occurs mostly in children and has been reported to follow 
the lines of Blaschko. The primary lesions (small, flat, 
skin‑colored to pink papules) can disappear spontaneously 
after several months or years, often leaving a linear macular 
hypopigmentation (post‑inflammatory).[11] Other skin 
infections/inflammations  like  impetigo and chickenpox, 
tuberculoid leprosy, insect bites, atopic dermatitis, physical 
agents such as burns or minor injuries or pytiriasis 
lichenoides chronica, hypopigmented mycosis fungoides 
and progressive macular hypomelanosis can also cause 
secondary or post‑inflammatory hypopigmentation.[28] The 
latter four disorders usually manifest at later age, but can 
be present during puberty or adolescence.
Hypopigmentation without pigment disorder
Naevus anaemicus is a solitary hypopigmented lesion, 
characterized by well‑defined, irregularly shaped, 
confluent maculae. On histological examination, 
a normal presence of melanocytes and melanin is 
seen. This lesion is present from birth and most often 
located on the trunk. The underlying mechanism is an 
aberrant, hypersensitive response to catecholamines, 
resulting in pallor of the skin. Hence, it has been called 
a pharmacological naevus. When the skin in these 
lesions is rubbed, no red coloring is observed as there is 
no vasodilatation possible.[29] A similar pale skin can be 
observed in Bier’s spots, which is also linked to vascular 
changes. They are usually found on the arms and legs 
of young adults as small, hypopigmented macules. The 
intervening skin may seem erythematous but blanches 
with pressure so that the pale macules disappear. This 
is in general a physiological vascular anomaly.
CONCLUSION
As hypomelanoses of the child can fit a wide range of 
pigment disorders, this review focused on the practical 
approach and differential diagnosis. Information about 
age of onset, distribution of lesions and degree of 
pigment loss should lead the clinician in routine clinical 
practice. Additional neurological, pediatric and genetic 
research can be important to detect associated conditions.
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